EUVIMEDEUVIMED entdecken
Crossref

Impact of preoperative mitral regurgitation on left ventricular assist device patients: propensity score-matched analysis of the EUROMACS dataset

Antonio Loforte iD, Gaik Nersesian iD, Daniel Lewin iD, Pia Lanmueller, Gregorio Gliozzi iD, Julia Stein iD, Giulio Giovanni Cavalli iD, Felix Schoenrath iD, Ivan Netuka iD, Daniel Zimpfer iD, Theo M M H de By iD, Jan Gummert iD und 5 weitere

European Journal of Cardio-Thoracic Surgery · 2023

DOI: 10.1093/ejcts/ezad013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Antonio Loforte und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, S. Orsola University Hospital, IRCCS Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart-Assist Devices, Heart Failure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: EACTS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES Mitral regurgitation (MR) is frequently observed in patients undergoing left ventricular assist device implantation. We investigated the impact of preoperative MR on left ventricular assist device patients. METHODS A retrospective propensity score-matched analysis of adult patients enrolled in the EUROMACS registry between 1 January 2011 and 30 November 2021 was performed. Patients were divided into 2 groups according to the grade of preoperative MR: none-to-mild (MR 0–II) or moderate-to-severe (MR III–IV). RESULTS Following 1:1 propensity score matching, each group consisted of 914 patients. Incidence of postoperative temporary right ventricular support, reoperation for bleeding and dialysis was similar. MR III–IV demonstrated shorter median intensive care unit stay [14 days (6; 27.8) vs 10 days (5; 22), P = 0.004] and ventilation time [72 h (22, 320) vs 31 h (18, 150), P < 0.001]. Mortality was lower for MR III–IV patients [subdistribution hazard ratio: 0.66, 95% confidence interval (CI): 0.59–0.73, P < 0.001]. The 1-year survival was 68.1% (95% CI: 65.1–71.3%) in MR 0–II and 75% (95% CI: 72.1–78%) in MR III–IV. A lower incidence of total complications [odds ratio (OR): 0.93 (0.89–0.98), P = 0.003] and trend towards a lower risk of neurological dysfunction (subdistribution hazard ratio: 0.79; 95% CI: 0.61–1.01, P = 0.063) and sustained ventricular tachycardia [OR: 0.93 (0.54–1.03), P = 0.074] were demonstrated for MR III–IV. The risk of fatal stroke and pump thrombosis was similar. CONCLUSIONS Moderate-to-severe MR in patients undergoing left ventricular assist device implantation is associated with better mid-term survival and lower incidence of total major adverse events and complications. The incidence of severe postoperative complications including fatal stroke and device thrombosis was similar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyHeart-Assist DevicesHeart FailureAdultHumansRetrospective StudiesPropensity ScoreTreatment Outcome

Stichwörter der Autor:innen

Advanced heart failureEUROMACSLeft ventricular assist deviceMitral regurgitation

Autor:innen und Institutionen

  • Department of Cardiac Surgery, S. Orsola University Hospital, IRCCS Bologna, Bologna, Italy.
  • Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
  • Department of Cardiovascular Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Antonio Loforte, Gaik Nersesian, Daniel Lewin, Gregorio Gliozzi, Julia Stein, Giulio Giovanni Cavalli, Felix Schoenrath, Ivan Netuka, Daniel Zimpfer, Theo M M H de By, Jan Gummert, Volkmar Falk, Bart Meyns, Gloria Faerber, Davide Pacini, Evgenij Potapov

Förderung

  • EACTS

Zitieren

APA

Loforte, A., Nersesian, G., Lewin, D., Lanmueller, P., Gliozzi, G., Stein, J., Cavalli, G. G., Schoenrath, F., Netuka, I., Zimpfer, D., de By, T. M. M. H., Gummert, J., Falk, V., Meyns, B., Faerber, G., Pacini, D., & Potapov, E. (2023). Impact of preoperative mitral regurgitation on left ventricular assist device patients: propensity score-matched analysis of the EUROMACS dataset. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad013

Vancouver

Loforte A, Nersesian G, Lewin D, Lanmueller P, Gliozzi G, Stein J, et al. Impact of preoperative mitral regurgitation on left ventricular assist device patients: propensity score-matched analysis of the EUROMACS dataset. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad013

BibTeX
@article{Loforte2023,
  author = {Loforte, Antonio and Nersesian, Gaik and Lewin, Daniel and Lanmueller, Pia and Gliozzi, Gregorio and Stein, Julia and Cavalli, Giulio Giovanni and Schoenrath, Felix and Netuka, Ivan and Zimpfer, Daniel and de By, Theo M M H and Gummert, Jan and Falk, Volkmar and Meyns, Bart and Faerber, Gloria and Pacini, Davide and Potapov, Evgenij},
  title = {Impact of preoperative mitral regurgitation on left ventricular assist device patients: propensity score-matched analysis of the EUROMACS dataset},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2023},
  doi = {10.1093/ejcts/ezad013}
}
Kostenlos starten →